1-hexadecyl-2-acetyl-glycero-3-phosphocholine and palmitoylcarnitine

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with palmitoylcarnitine in 2 studies

Compound Research Comparison

Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine)	Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine)	Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine)	Studies (palmitoylcarnitine)	Trials (palmitoylcarnitine)	Recent Studies (post-2010) (palmitoylcarnitine)
9,156	187	552	412	1	65

Protein Interaction Comparison

Protein	Taxonomy	1-hexadecyl-2-acetyl-glycero-3-phosphocholine (IC50)	palmitoylcarnitine (IC50)
Sodium- and chloride-dependent glycine transporter 2	Homo sapiens (human)		0.6

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	2 (100.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Arese, P; Bussolino, F; Fischer, E; Kazatchkine, MD; Turrini, F	1
McIntyre, TM; Prescott, SM; Reinhold, SL; Zimmerman, GA	1

Other Studies

2 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and palmitoylcarnitine

Article	Year
Platelet-activating factor enhances complement-dependent phagocytosis of diamide-treated erythrocytes by human monocytes through activation of protein kinase C and phosphorylation of complement receptor type one (CR1). The Journal of biological chemistry, 1989, Dec-25, Volume: 264, Issue:36 Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Alkaloids; Azo Compounds; Cell Adhesion; Complement System Proteins; Diamide; Enzyme Activation; Erythrocytes; Humans; In Vitro Techniques; Isoquinolines; Kinetics; Monocytes; Palmitoylcarnitine; Phagocytosis; Phosphorylation; Piperazines; Platelet Activating Factor; Protein Kinase C; Receptors, Complement; Sphingosine; Staurosporine; Structure-Activity Relationship	1989
Protein kinase C activity appears to be required for the synthesis of platelet-activating factor and leukotriene B4 by human neutrophils. The Journal of biological chemistry, 1987, Nov-15, Volume: 262, Issue:32 Topics: Amines; Enzyme Activation; Humans; Leukotriene B4; Neutrophils; Palmitoylcarnitine; Platelet Activating Factor; Protein Kinase C; Sphingosine; Tetradecanoylphorbol Acetate	1987

Article

Year

Platelet-activating factor enhances complement-dependent phagocytosis of diamide-treated erythrocytes by human monocytes through activation of protein kinase C and phosphorylation of complement receptor type one (CR1).

The Journal of biological chemistry, 1989, Dec-25, Volume: 264, Issue:36

Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Alkaloids; Azo Compounds; Cell Adhesion; Complement System Proteins; Diamide; Enzyme Activation; Erythrocytes; Humans; In Vitro Techniques; Isoquinolines; Kinetics; Monocytes; Palmitoylcarnitine; Phagocytosis; Phosphorylation; Piperazines; Platelet Activating Factor; Protein Kinase C; Receptors, Complement; Sphingosine; Staurosporine; Structure-Activity Relationship

1989

Protein kinase C activity appears to be required for the synthesis of platelet-activating factor and leukotriene B4 by human neutrophils.

The Journal of biological chemistry, 1987, Nov-15, Volume: 262, Issue:32

Topics: Amines; Enzyme Activation; Humans; Leukotriene B4; Neutrophils; Palmitoylcarnitine; Platelet Activating Factor; Protein Kinase C; Sphingosine; Tetradecanoylphorbol Acetate

1987